Yong Yean Kim

6PUBLICATIONS
57CO-AUTHORS
Molecular targetsHaematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 08, 2026
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.

|Aug 08, 2025
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma.

Elizabeth A Mendes, Aanandi Munshi, Archana Singh

|Jul 23, 2024
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma.

Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk

|Feb 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Yong Yean Kim, Berkley E Gryder, Ranuka Sinniah

|Jan 06, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.

Katherine E Masih, Rebecca A Gardner, Hsien-Chao Chou

|Jul 14, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.

Hiroto Ohguchi, Paul M C Park, Tingjian Wang

Pageof 1

Frequent Collaborators

5 joint publications

Hsien-Chao Chou

4 joint publications

Javed Khan

4 joint publications

Jun S Wei

4 joint publications

David Milewski